Tamoxifen

The Lancet: January 21, 2011

Listen to The Lancet

15 years ago

The Lancet: January 21, 2011

breast cancer

tamoxifen

aromatase inhibitors

exemestane

hormone receptors

+5

+5

+4

+4

+3

+3

+3

+2

+1

12:17

breast cancer

tamoxifen

aromatase inhibitors

exemestane

hormone receptors

+5

+5

+4

+4

+3

+3

+3

+2

+1

Journal of Clinical Oncology P

15 years ago

Is Genotype Guided Tamoxifen Dosing Ready for Prime Time?

pharmacogenomics

tamoxifen

endoxifen

guideddosemodulation

+4

+4

+3

+3

+2

+2

+1

+1

pharmacogenomics

tamoxifen

endoxifen

guideddosemodulation

+4

+4

+3

+3

+2

+2

+1

+1

FirstWord Pharmaceutical News

17 years ago

FirstWord Pharmaceutical News for Wednesday August 26, 2009

tamoxifen

off-label prescribing

human genome sciences

glaxosmithkline

aranesp

+5

+4

+4

+4

+3

+3

+3

+2

+2

09:50

tamoxifen

off-label prescribing

human genome sciences

glaxosmithkline

aranesp

+5

+4

+4

+4

+3

+3

+3

+2

+2

FirstWord Pharmaceutical News

10 years ago

FirstWord Pharmaceutical News for Thursday, December 6, 2012

tamoxifen

pfizer

pd-0332991

chelsea therapeutics

eli lilly

+5

+4

+3

+3

+3

+2

+2

+2

10:24

tamoxifen

pfizer

pd-0332991

chelsea therapeutics

eli lilly

+5

+4

+3

+3

+3

+2

+2

+2

The Lancet: December 18, 2009

Listen to The Lancet

16 years ago

The Lancet: December 18, 2009

breast cancer

tamoxifen

chemotherapy

menopause

node positive

+5

+5

+4

+4

+3

+3

+3

+2

+1

11:01

breast cancer

tamoxifen

chemotherapy

menopause

node positive

+5

+5

+4

+4

+3

+3

+3

+2

+1

The Lancet Oncology: June 24, 2011

Listen to The Lancet Oncology

15 years ago

The Lancet Oncology: June 24, 2011

breast cancer

menopause

tamoxifen

bisphosphinates

zoledronic acid

+5

+5

+4

+4

+3

+3

+2

+2

+1

breast cancer

menopause

tamoxifen

bisphosphinates

zoledronic acid

+5

+5

+4

+4

+3

+3

+2

+2

+1

FirstWord Pharmaceutical News

10 years ago

FirstWord Pharmaceutical News for Tuesday, April 20, 2010

eli lilly

avandia

novartis

oriel

tamoxifen

+4

+4

+3

+3

+2

+2

+1

10:38

eli lilly

avandia

novartis

oriel

tamoxifen

+4

+4

+3

+3

+2

+2

+1

Institute for Healthcare Impro

20 years ago

Author in the Room: The Effects of Tamoxifen versus Raloxifene on the Risk of Developing Invasive Br

tamoxifen

raloxifene

+2

+1

56:05

tamoxifen

raloxifene

+2

+1

FirstWord Pharmaceutical News

17 years ago

FirstWord Pharmaceutical News for Thursday November 13, 2008

bisphosphonates

avandia

tamoxifen

lundbeck

embeda

+5

+5

+4

+4

+3

+3

+2

+2

07:32

bisphosphonates

avandia

tamoxifen

lundbeck

embeda

+5

+5

+4

+4

+3

+3

+2

+2

The Lancet Oncology: January 06, 2010

Listen to The Lancet Oncology

16 years ago

The Lancet Oncology: January 06, 2010

cancer

breast cancer

tamoxifen

chemotherapy

menopause

+4

+4

+4

+3

+3

+3

+2

+2

cancer

breast cancer

tamoxifen

chemotherapy

menopause

+4

+4

+4

+3

+3

+3

+2

+2